JP2022544760A5 - - Google Patents

Info

Publication number
JP2022544760A5
JP2022544760A5 JP2022507875A JP2022507875A JP2022544760A5 JP 2022544760 A5 JP2022544760 A5 JP 2022544760A5 JP 2022507875 A JP2022507875 A JP 2022507875A JP 2022507875 A JP2022507875 A JP 2022507875A JP 2022544760 A5 JP2022544760 A5 JP 2022544760A5
Authority
JP
Japan
Prior art keywords
cys
scfv
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022544760A (ja
JP7797373B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046303 external-priority patent/WO2021030657A1/en
Publication of JP2022544760A publication Critical patent/JP2022544760A/ja
Priority to JP2025042288A priority Critical patent/JP2025094049A/ja
Publication of JP2022544760A5 publication Critical patent/JP2022544760A5/ja
Application granted granted Critical
Publication of JP7797373B2 publication Critical patent/JP7797373B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507875A 2019-08-15 2020-08-14 改善された単鎖可変断片のための材料及び方法 Active JP7797373B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025042288A JP2025094049A (ja) 2019-08-15 2025-03-17 改善された単鎖可変断片のための材料及び方法

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US201962887519P 2019-08-15 2019-08-15
US201962887529P 2019-08-15 2019-08-15
US201962887527P 2019-08-15 2019-08-15
US201962887524P 2019-08-15 2019-08-15
US201962887514P 2019-08-15 2019-08-15
US62/887,519 2019-08-15
US62/887,529 2019-08-15
US62/887,527 2019-08-15
US62/887,524 2019-08-15
US62/887,514 2019-08-15
US201962946865P 2019-12-11 2019-12-11
US201962946897P 2019-12-11 2019-12-11
US201962946886P 2019-12-11 2019-12-11
US201962946877P 2019-12-11 2019-12-11
US201962946882P 2019-12-11 2019-12-11
US62/946,897 2019-12-11
US62/946,886 2019-12-11
US62/946,865 2019-12-11
US62/946,882 2019-12-11
US62/946,877 2019-12-11
PCT/US2020/046303 WO2021030657A1 (en) 2019-08-15 2020-08-14 Materials and methods for improved single chain variable fragments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025042288A Division JP2025094049A (ja) 2019-08-15 2025-03-17 改善された単鎖可変断片のための材料及び方法

Publications (3)

Publication Number Publication Date
JP2022544760A JP2022544760A (ja) 2022-10-21
JP2022544760A5 true JP2022544760A5 (cg-RX-API-DMAC7.html) 2025-09-17
JP7797373B2 JP7797373B2 (ja) 2026-01-13

Family

ID=72243247

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022507875A Active JP7797373B2 (ja) 2019-08-15 2020-08-14 改善された単鎖可変断片のための材料及び方法
JP2025042288A Pending JP2025094049A (ja) 2019-08-15 2025-03-17 改善された単鎖可変断片のための材料及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025042288A Pending JP2025094049A (ja) 2019-08-15 2025-03-17 改善された単鎖可変断片のための材料及び方法

Country Status (19)

Country Link
US (2) US11787875B2 (cg-RX-API-DMAC7.html)
EP (1) EP4013783A1 (cg-RX-API-DMAC7.html)
JP (2) JP7797373B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220062494A (cg-RX-API-DMAC7.html)
CN (1) CN114258400A (cg-RX-API-DMAC7.html)
AU (1) AU2020328049A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022002540A2 (cg-RX-API-DMAC7.html)
CA (1) CA3148121A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022001222A2 (cg-RX-API-DMAC7.html)
CR (1) CR20220054A (cg-RX-API-DMAC7.html)
DO (1) DOP2022000032A (cg-RX-API-DMAC7.html)
EC (1) ECSP22011199A (cg-RX-API-DMAC7.html)
IL (1) IL290436A (cg-RX-API-DMAC7.html)
JO (1) JOP20220035A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022001799A (cg-RX-API-DMAC7.html)
PE (1) PE20220299A1 (cg-RX-API-DMAC7.html)
PH (1) PH12022550348A1 (cg-RX-API-DMAC7.html)
TW (1) TW202120537A (cg-RX-API-DMAC7.html)
WO (1) WO2021030657A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021116337A1 (en) * 2019-12-11 2021-06-17 Cilag Gmbh International Multispecific binding molecules comprising ltbr and edb binding domains and uses thereof
WO2021231976A1 (en) 2020-05-14 2021-11-18 Xencor, Inc. Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
US11919958B2 (en) 2020-08-19 2024-03-05 Xencor, Inc. Anti-CD28 compositions
AR125210A1 (es) * 2021-03-24 2023-06-21 Janssen Biotech Inc Anticuerpos dirigidos a cd22 y cd79b
EP4436669A1 (en) * 2021-11-22 2024-10-02 Janssen Biotech, Inc. Compositions comprising enhanced multispecific binding agents for an immune response
WO2023152581A1 (en) 2022-02-09 2023-08-17 Janssen Biotech, Inc. Method of treating cancer with psmaxcd3 antibody
IL314993A (en) 2022-02-23 2024-10-01 Xencor Inc Anti-cd28 x anti-psma antibodies
EP4565331A1 (en) 2022-08-05 2025-06-11 Janssen Biotech, Inc. Cd98 binding constructs for treating brain tumors
CN120077064A (zh) 2022-08-05 2025-05-30 詹森生物科技公司 用于治疗脑肿瘤的转铁蛋白受体结合蛋白
CN121925428A (zh) 2023-07-30 2026-04-24 詹森生物科技公司 结合突变钙网蛋白的分子及其用途
EP4758173A1 (en) 2023-08-07 2026-06-17 Janssen Biotech, Inc. Enpp3 and cd3 binding agents and methods of use thereof
AU2024321510A1 (en) 2023-08-07 2026-03-26 Janssen Biotech, Inc. Stabilized cd3 antigen binding agents and methods of use thereof
IL326398A (en) * 2023-08-07 2026-04-01 Janssen Biotech Inc Gucy2c antibodies and uses thereof
KR20260081298A (ko) 2023-08-28 2026-06-02 젠코어 인코포레이티드 항-cd20 x 항-cd28 조합 요법
WO2025088587A1 (en) * 2023-10-27 2025-05-01 Janssen Biotech, Inc. Compositions comprising enhanced multispecific binding agents for an immune response
US20250376509A1 (en) 2023-11-21 2025-12-11 Janssen Biotech, Inc. Methods for treatment of myeloproliferative neoplasms
AU2024401943A1 (en) 2023-12-12 2026-07-30 Janssen Biotech, Inc. Enpp3 × cd3 bispecific antibodies and use thereof
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
WO2025172924A1 (en) 2024-02-15 2025-08-21 Janssen Biotech, Inc. Anti-transferrin receptor compositions and methods thereof
US20250361317A1 (en) 2024-05-24 2025-11-27 Janssen Biotech, Inc. Bispecific antibody targeting emr2 (cd312) and the t-cell receptor trbv19
WO2025251110A1 (en) * 2024-06-03 2025-12-11 Selvax Pty Ltd Anti-cd40 antibody il-2 fusion proteins
WO2025259749A1 (en) * 2024-06-12 2025-12-18 Amgen Inc. Stable single-chain variable fragments
WO2026035888A1 (en) 2024-08-06 2026-02-12 Janssen Biotech, Inc. Methods and compositions for modulating beta chain mediated immunity
WO2026055669A2 (en) 2024-09-09 2026-03-12 Xencor, Inc. Anti-tl1a x anti-il23 antibodies
WO2026093993A1 (en) 2024-11-01 2026-05-07 Janssen Biotech, Inc. Methods and systems for enhanced multispecific metabolic and cellular targeting
WO2026136805A1 (en) 2024-12-19 2026-06-25 Agni Bio, Inc. Methods and compositions for modulating v-beta-17 chain mediated immunity

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
US5932448A (en) 1991-11-29 1999-08-03 Protein Design Labs., Inc. Bispecific antibody heterodimers
US5635483A (en) 1992-12-03 1997-06-03 Arizona Board Of Regents Acting On Behalf Of Arizona State University Tumor inhibiting tetrapeptide bearing modified phenethyl amides
US5780588A (en) 1993-01-26 1998-07-14 Arizona Board Of Regents Elucidation and synthesis of selected pentapeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
DE60131456T2 (de) 2000-11-30 2008-07-10 Medarex, Inc., Milpitas Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern
US6884869B2 (en) 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
KR101374454B1 (ko) 2005-03-31 2014-03-17 추가이 세이야쿠 가부시키가이샤 회합제어에 의한 폴리펩티드 제조방법
DE102005028778A1 (de) 2005-06-22 2006-12-28 SUNJÜT Deutschland GmbH Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage
EA015992B1 (ru) * 2006-03-17 2012-01-30 Байоджен Айдек Эмэй Инк. Стабилизированное антитело и многовалентная антигенсвязывающая молекула на его основе, способы получения и использования вышеназванного стабилизированного антитела
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
WO2007147901A1 (en) 2006-06-22 2007-12-27 Novo Nordisk A/S Production of bispecific antibodies
US20080226635A1 (en) 2006-12-22 2008-09-18 Hans Koll Antibodies against insulin-like growth factor I receptor and uses thereof
CA2682851C (en) 2007-04-02 2017-01-17 Philogen S.P.A. A novel antigen associated with the neovasculature of tumour metastases
AU2008343589A1 (en) 2007-12-19 2009-07-09 Centocor Ortho Biotech Inc. Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods
EP2282769A4 (en) 2008-04-29 2012-04-25 Abbott Lab DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
RU2582244C2 (ru) * 2008-06-30 2016-04-20 ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи Функционализированные полипептиды
US9067986B2 (en) 2009-04-27 2015-06-30 Oncomed Pharmaceuticals, Inc. Method for making heteromultimeric molecules
TWI507525B (zh) 2009-06-26 2015-11-11 Regeneron Pharma 具天然免疫球蛋白形式之易分離的雙專一性抗體
RU2583876C2 (ru) 2009-08-17 2016-05-10 Роше Гликарт Аг Иммуноконъюгаты направленного действия
WO2011030107A1 (en) * 2009-09-10 2011-03-17 Ucb Pharma S.A. Multivalent antibodies
CA2784610C (en) * 2009-12-23 2020-07-14 Avipep Pty Ltd Immuno-conjugates and methods for producing them
GB201005064D0 (en) * 2010-03-25 2010-05-12 Ucb Pharma Sa Biological products
PT2560993T (pt) 2010-04-20 2024-09-16 Genmab As Proteínas contendo anticorpo heterodimérico fc e métodos para a produção das mesmas
WO2011143545A1 (en) 2010-05-14 2011-11-17 Rinat Neuroscience Corporation Heterodimeric proteins and methods for producing and purifying them
EP2420253A1 (en) 2010-08-20 2012-02-22 Leadartis, S.L. Engineering multifunctional and multivalent molecules with collagen XV trimerization domain
CN103068846B9 (zh) 2010-08-24 2016-09-28 弗·哈夫曼-拉罗切有限公司 包含二硫键稳定性Fv片段的双特异性抗体
CN103429620B (zh) 2010-11-05 2018-03-06 酵活有限公司 在Fc结构域中具有突变的稳定异源二聚的抗体设计
TWI622597B (zh) * 2011-03-28 2018-05-01 賽諾菲公司 具有交叉結合區定向之雙重可變區類抗體結合蛋白
IN2014CN03887A (cg-RX-API-DMAC7.html) 2011-10-27 2015-10-16 Genmab As
US9574010B2 (en) 2011-11-04 2017-02-21 Zymeworks Inc. Stable heterodimeric antibody design with mutations in the Fc domain
US9527927B2 (en) 2011-12-20 2016-12-27 Medimmune, Llc Modified polypeptides for bispecific antibody scaffolds
WO2013157953A1 (en) 2012-04-20 2013-10-24 Merus B.V. Methods and means for the production of ig-like molecules
JP5550797B2 (ja) 2012-05-24 2014-07-16 パナソニック株式会社 ヒト心筋由来トロポニンiに特異的にかつ速やかに結合できる変異体タンパク質
PT2970980T (pt) 2013-03-15 2018-11-19 Janssen Biotech Inc Métodos de produção para controlor o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes
US20160326249A1 (en) * 2014-01-15 2016-11-10 Zymeworks Inc. Bi-specific cd3 and cd19 antigen-binding constructs
CN109843926B (zh) 2016-09-30 2023-01-20 豪夫迈·罗氏有限公司 针对cd3的双特异性抗体
EP3684816B1 (en) 2017-09-22 2024-05-29 Kite Pharma, Inc. Chimeric polypeptides and uses thereof
GB201721421D0 (en) * 2017-12-20 2018-01-31 Ucl Business Plc Chimeric antigen receptor

Similar Documents

Publication Publication Date Title
US12152076B2 (en) Bispecific and monospecific antibodies using novel anti-PD-1 sequences
US10793621B2 (en) Nucleic acid encoding dual Fc antigen binding proteins
JP7566766B2 (ja) 抗Vβ17/抗CD123二重特異性抗体
JP7450535B2 (ja) 単一特異性抗体から多重特異性抗体を生成させるための方法
JP2022544760A (ja) 改善された単鎖可変断片のための材料及び方法
JP7645799B2 (ja) ヘテロダイマー抗体の作製方法
CA2824824A1 (en) Monovalent antigen binding proteins
CA2761233A1 (en) Tri- or tetraspecific antibodies
WO2013164325A1 (en) Multispecific antigen binding proteins
WO2025245176A1 (en) Multispecific antibody constructs
JP2026506906A (ja) 抗Vβ17/抗CD123二重特異性抗体
WO2025108310A1 (zh) 通过重组反应制备异源多聚体的方法
WO2026050570A1 (en) Engineered protein constructs targeting siglec-8 and cd117
HK40031028A (en) Method for generating multispecific antibodies from monospecific antibodies
HK40031028B (en) Method for generating multispecific antibodies from monospecific antibodies
HK1189904A (en) Antigen binding proteins